FindTrial
Sign In

The effect of renal sympathethic denernation on frequency premature ventricular contractions

The effect of renal sympathethic denernation on frequency premature ventricular contractions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-14004204
Enrollment
Unknown
Registered
2014-01-22
Start date
2014-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frequent Premature Ventricular Contraction

Interventions

RDN group:renal sympathethic denernation
AAM Group:anti-arrhythmia medicine(Cordarone (Sanofi-Aventis) 0.2 g once per day or Metoprolol succinate sustained-release tablets (AstraZeneca AB) 23.75–47.5 mg per day)

Sponsors

Department of Cardiology, Daping Hospital, The Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients were suffered with FPVCs by HOLTER, and the FPVCs was more than 1000 per 24 hours. The effect of drugs was bad.

Exclusion criteria

Exclusion criteria: All patients underwent extensive baseline evaluation to rule out any structural disease, including rheumatic heart disease, endocrine disease, hyperthyroidism, thyroid dysfunction, arrhythmogenic medicine and electrolyte disturbances.

Design outcomes

Primary

MeasureTime frame
Hote ECG;—

Countries

China

Contacts

Public ContactYuqiang Fang

Department of Cardiology, Daping Hospital, The Third Military Medical University

yuqfang@163.com+86 13036310928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026